Neuren Pharmaceuticals Limited(AU:NEU)
A$23.96-0.24 (-0.99%)
AU:NEU
Neuren Pharmaceuticals Limited financials statements
A$23.96
At close:-0.24 (-0.99%)
Want to see AU:NEU full AI Analyst Report?
Neuren Pharmaceuticals Limited (NEU) Income Statement
287 Followers
Neuren Pharmaceuticals Limited Income Statement
Last quarter (Q2 2026), Neuren Pharmaceuticals Limited's total revenue was AU$33.16M, an increase of 36.29% from the same quarter last year. In Q2, Neuren Pharmaceuticals Limited's net income was AU$4.85M. See Neuren Pharmaceuticals Limited’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| AU$ 64.63M | AU$ 213.24M | AU$ 231.93M | AU$ 14.55M | AU$ 3.20M | |
| AU$ 64.61M | AU$ 213.22M | AU$ 205.17M | AU$ 14.54M | AU$ 3.19M | |
| AU$ 42.59M | AU$ 37.67M | AU$ 32.70M | AU$ 16.14M | AU$ 11.42M | |
| Depreciation and Amortization | AU$ 23.00K | AU$ 22.00K | AU$ 17.00K | AU$ 10.00K | AU$ 8.00K |
| AU$ 22.05M | AU$ 175.57M | AU$ 199.26M | AU$ -670.00K | AU$ -10.98M | |
| AU$ 22.02M | AU$ 175.55M | AU$ 172.49M | AU$ -1.60M | AU$ -11.43M | |
| AU$ 16.91M | AU$ 7.39M | AU$ 32.65M | AU$ 916.00K | AU$ 439.00K | |
| AU$ 38.93M | AU$ 182.94M | AU$ 205.14M | AU$ -680.00K | AU$ -10.99M | |
| AU$ 30.44M | AU$ 142.04M | AU$ 157.08M | AU$ 184.00K | AU$ -7.79M | |
| Per Share Metrics | |||||
| Basic EPS | AU$ 0.24 | AU$ 1.11 | AU$ 1.24 | AU$ 0.00 | AU$ -0.07 |
| Diluted EPS | AU$ 0.23 | AU$ 1.09 | AU$ 1.20 | AU$ 0.00 | AU$ -0.07 |
| Weighted Average Shares Outstanding | 128.24M | 127.77M | 127.07M | 125.97M | 117.77M |
| Weighted Average Shares Outstanding (Diluted) | 130.77M | 130.78M | 130.77M | 128.91M | 117.77M |
Currency in AUD
